Publication: CRISPR-Cas3 induces broad and unidirectional genome editing in human cells
dc.contributor.author | Hiroyuki Morisaka | en_US |
dc.contributor.author | Kazuto Yoshimi | en_US |
dc.contributor.author | Yuya Okuzaki | en_US |
dc.contributor.author | Peter Gee | en_US |
dc.contributor.author | Yayoi Kunihiro | en_US |
dc.contributor.author | Ekasit Sonpho | en_US |
dc.contributor.author | Huaigeng Xu | en_US |
dc.contributor.author | Noriko Sasakawa | en_US |
dc.contributor.author | Yuki Naito | en_US |
dc.contributor.author | Shinichiro Nakada | en_US |
dc.contributor.author | Takashi Yamamoto | en_US |
dc.contributor.author | Shigetoshi Sano | en_US |
dc.contributor.author | Akitsu Hotta | en_US |
dc.contributor.author | Junji Takeda | en_US |
dc.contributor.author | Tomoji Mashimo | en_US |
dc.contributor.other | Center for iPS Cell Research and Application | en_US |
dc.contributor.other | Institute of Medical Science The University of Tokyo | en_US |
dc.contributor.other | Hiroshima University | en_US |
dc.contributor.other | Osaka University | en_US |
dc.contributor.other | National Institute of Genetics Mishima | en_US |
dc.contributor.other | Kochi University | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | Database Center for Life Science (DBCLS) | en_US |
dc.date.accessioned | 2020-01-27T07:35:22Z | |
dc.date.available | 2020-01-27T07:35:22Z | |
dc.date.issued | 2019-12-01 | en_US |
dc.description.abstract | © 2019, The Author(s). Although single-component Class 2 CRISPR systems, such as type II Cas9 or type V Cas12a (Cpf1), are widely used for genome editing in eukaryotic cells, the application of multi-component Class 1 CRISPR has been less developed. Here we demonstrate that type I-E CRISPR mediates distinct DNA cleavage activity in human cells. Notably, Cas3, which possesses helicase and nuclease activity, predominantly triggered several thousand base pair deletions upstream of the 5′-ARG protospacer adjacent motif (PAM), without prominent off-target activity. This Cas3-mediated directional and broad DNA degradation can be used to introduce functional gene knockouts and knock-ins. As an example of potential therapeutic applications, we show Cas3-mediated exon-skipping of the Duchenne muscular dystrophy (DMD) gene in patient-induced pluripotent stem cells (iPSCs). These findings broaden our understanding of the Class 1 CRISPR system, which may serve as a unique genome editing tool in eukaryotic cells distinct from the Class 2 CRISPR system. | en_US |
dc.identifier.citation | Nature Communications. Vol.10, No.1 (2019) | en_US |
dc.identifier.doi | 10.1038/s41467-019-13226-x | en_US |
dc.identifier.issn | 20411723 | en_US |
dc.identifier.other | 2-s2.0-85076283383 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/50021 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85076283383&origin=inward | en_US |
dc.subject | Biochemistry, Genetics and Molecular Biology | en_US |
dc.subject | Chemistry | en_US |
dc.title | CRISPR-Cas3 induces broad and unidirectional genome editing in human cells | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85076283383&origin=inward | en_US |